Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/25/2004 | CA2498776A1 Gene expression system based on codon translation efficiency |
03/25/2004 | CA2498770A1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
03/25/2004 | CA2496319A1 Mammalian megakaryocyte progenitor cell |
03/25/2004 | CA2494216A1 Use of dendritic cells (dcs) expressing interleukin 12 (il-12) |
03/24/2004 | EP1400807A2 Use of novel stem cell markers for isolation of intestinal stem cells, and use of the intestinal stem cells thus obtained for the preparation of a therapeutical composition |
03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
03/24/2004 | EP1400587A1 Use of a fusion polypeptide for obtaining pluripotent non-embryonic stem cells |
03/24/2004 | EP1400584A2 Roller Bottle |
03/24/2004 | EP1399740A2 Type 1 diabetes diagnostics and therapeutics |
03/24/2004 | EP1399589A2 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders |
03/24/2004 | EP1399587A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
03/24/2004 | EP1399575A2 Methods of modifying eukaryotic cells |
03/24/2004 | EP1399574A2 Improved vectors for gene therapy |
03/24/2004 | EP1399571A2 Modulating developmental transitions in plants |
03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
03/24/2004 | EP1399568A2 Method for producing recombinant trypsin |
03/24/2004 | EP1399567A1 Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase |
03/24/2004 | EP1399566A2 Novel glyphosate n-acetyltransferase (gat) genes |
03/24/2004 | EP1399565A2 Mitogenic oxygenase regulators |
03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
03/24/2004 | EP1399558A2 Vanilloid receptor-related nucleic acids and polypeptides |
03/24/2004 | EP1399557A2 Brain expressed gene and protein associated with bipolar disorder |
03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
03/24/2004 | EP1399551A2 Method for separating bacterial cells and cell components |
03/24/2004 | EP1399549A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
03/24/2004 | EP1399545A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
03/24/2004 | EP1399541A2 N4 virion single-stranded dna dependent rna polymerase |
03/24/2004 | EP1399540A2 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
03/24/2004 | EP1399538A2 Engineering intracellular sialylation pathways |
03/24/2004 | EP1399537A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
03/24/2004 | EP1399484A2 Dual-specific ligand and its use |
03/24/2004 | EP1399483A2 Antibodies to insulin-like growth factor i receptor |
03/24/2004 | EP1399479A2 Cation conducting gaba a receptors and their use |
03/24/2004 | EP1399472A2 Soluble heterodimeric cytokine receptor |
03/24/2004 | EP1399183A2 Chimeric alphavirus replicon particles |
03/24/2004 | EP1399168A1 Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours |
03/24/2004 | EP1399110A2 Antibodies abolish prion propagation and promote clearance of infectivity |
03/24/2004 | EP1399109A2 Separation of platelets from whole blood for use as a healant |
03/24/2004 | EP1399016A2 Method for generating diversity |
03/24/2004 | EP1231947B1 Injectable bone-substitute material comprising fibrin or fibrinogen and hydroxyapatite cement |
03/24/2004 | EP1231934B1 Methods of inhibiting atrophy or promoting hypertrophy |
03/24/2004 | EP0900002B1 H2-m modified transgenic animals |
03/24/2004 | EP0796277B1 Fusion junction type iii mutant egf receptor peptide tumour vaccine |
03/24/2004 | EP0795015B1 Plasmids suitable for il-2 expression |
03/24/2004 | EP0726953B1 Human kunitz-type protease inhibitors |
03/24/2004 | CN1484709A Method and compositions for isolating metastatic cancer cells and use in measuring metastatic potential of a cancer thereof |
03/24/2004 | CN1484707A Methods of modifying eukaryotic cells |
03/24/2004 | CN1484706A Photochemical internalization for virus-mediated molecule delivery into the cyosol |
03/24/2004 | CN1484705A Dan encoding a plant lipase transgenic plants and a method for controlling senescence in plants |
03/24/2004 | CN1484702A Novel bacillus thuringiensis insecticidal proteins |
03/24/2004 | CN1484699A Novel mutant allergens |
03/24/2004 | CN1484696A Putrescine-N-Methyl transferase promoter |
03/24/2004 | CN1484694A Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
03/24/2004 | CN1484692A Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing canceg said protooncogene |
03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
03/24/2004 | CN1484499A Method for molecular press dehydration of plant tissue using solid phase water-soluble polymer as de hydrating agent |
03/24/2004 | CN1484497A Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
03/24/2004 | CN1483822A Promotor for controlling plant root system development and use thereof |
03/24/2004 | CN1483821A Gene for controlling plant root system development and its coding products and use |
03/24/2004 | CN1483817A Method for cloning human embryonic stem cell without animal component |
03/24/2004 | CN1483806A Biological reactor for large scale culturing plant cell |
03/24/2004 | CN1483804A Kit for animal cell digestive inoculation and application thereof |
03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
03/24/2004 | CN1142941C Cells bearing CD4 decoy receptors and related molecules and methods |
03/23/2004 | US6710174 For therapy of cancer, disease or condition involves angiogenesis, and rheumatoid arthritis |
03/23/2004 | US6710172 Tumor antigens and CTL clones isolated by a novel procedure |
03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
03/23/2004 | US6710025 Administering platelet derived growth factor, interferons or transforming growth factor |
03/23/2004 | US6709864 Composition comprising isolated human mesenchymal stem cells in biocompatible matrix which supports differentiation and maturation of stem cells into adipocytes |
03/23/2004 | US6709848 Methods for isolating polyhydroxyalkanoates from plants |
03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
03/23/2004 | US6709839 SYK-UBP proteins, compositions and methods of use |
03/23/2004 | US6709838 Nucleic acid encoding patched-2 |
03/23/2004 | US6709837 Reagent for studies relating to the differentiation, growth and survival of animal cells, and may also be useful as a drug |
03/23/2004 | US6709835 Nutrient broth for determining intracellular activity of glutathione in lymphocytes |
03/23/2004 | US6709834 Hybrid nucleotide sequence |
03/23/2004 | US6709833 Antibody for use as tool in immunoassay |
03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
03/23/2004 | US6709811 Versatile reagent for detecting murine leukemia viruses |
03/23/2004 | US6709810 Methods for quenching pathogen inactivators in biological materials |
03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
03/23/2004 | CA2336207C Ecdysone receptors and methods for their use |
03/18/2004 | WO2004023100A2 Cd56 positive human adult pancreatic endocrine progenitor cells |
03/18/2004 | WO2004022764A2 Use of malate dehydrogenase for nadh regeneration |
03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
03/18/2004 | WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity |
03/18/2004 | WO2004022745A2 Reversible, parallel and multitask cloning method and kit |
03/18/2004 | WO2004022730A1 Immunotherapy using modulators of notch signalling |
03/18/2004 | WO2004022729A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
03/18/2004 | WO2004022726A1 Method of controlling biotic function through mechanical vibration and device therefor |
03/18/2004 | WO2004022709A2 Epitope sequences |
03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |